Skip to main content

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Abeona Therapeutics Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of ABEO: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders6571+6
Shares30.6M29.7M−946.8K (−3.1%)
Value$170.4M$141.2M−$29.2M (−17.1%)

New holders (14)

Institutions that held Abeona Therapeutics Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to ABEO in Q1 2025
InstitutionSharesValue% of portfolio
Kennedy Capital Management, Inc.621,763$2.96M0.07%
HRT Financial LP96,655$460.0K0.00%
Jain Global LLC45,940$218.7K0.00%
LMR Partners LLP27,120$129.1K0.00%
Quantessence Capital LLC26,087$124.2K0.03%
ExodusPoint Capital Management, LP24,409$116.0K0.00%
Engineers Gate Manager LP20,501$97.6K0.00%
Diametric Capital, LP18,754$89.3K0.11%
Cannon Global Investment Management, LLC14,000$66.6K0.18%
Creative Planning10,005$47.6K0.00%
Royal Bank of Canada1,954$9.00K0.00%
MAI Capital Management1,620$7.71K0.00%
Jones Financial Companies LLLP1,000$4.97K0.00%
Avion Wealth85$00.00%

Sold out (8)

Institutions that held Abeona Therapeutics Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of ABEO in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Aster Capital Management (DIFC) Ltd21,601$120.3K
Oxford Asset Management LLP21,121$117.6K
Twinbeech Capital LP10,425$58.1K
Tower Research Capital LLC (TRC)5,951$33.1K
R Squared Ltd4,160$23.2K
CI Private Wealth, LLC22,416$192
BNP Paribas Arbitrage, SA1$6
Lazard Asset Management LLC116$0